These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19156487)

  • 1. Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease.
    Thambisetty M; Hye A; Foy C; Daly E; Glover A; Cooper A; Simmons A; Murphy D; Lovestone S
    J Neurol; 2008 Nov; 255(11):1712-20. PubMed ID: 19156487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].
    Engelhardt E; Moreira DM; Laks J; Marinho VM; Rozenthal M; Oliveira AC
    Arq Neuropsiquiatr; 2001 Dec; 59(4):865-70. PubMed ID: 11733829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
    J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study.
    Schuff N; Amend D; Ezekiel F; Steinman SK; Tanabe J; Norman D; Jagust W; Kramer JH; Mastrianni JA; Fein G; Weiner MW
    Neurology; 1997 Dec; 49(6):1513-21. PubMed ID: 9409338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome-based plasma biomarkers for Alzheimer's disease.
    Hye A; Lynham S; Thambisetty M; Causevic M; Campbell J; Byers HL; Hooper C; Rijsdijk F; Tabrizi SJ; Banner S; Shaw CE; Foy C; Poppe M; Archer N; Hamilton G; Powell J; Brown RG; Sham P; Ward M; Lovestone S
    Brain; 2006 Nov; 129(Pt 11):3042-50. PubMed ID: 17071923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced hippocampal glutamate in Alzheimer disease.
    Rupsingh R; Borrie M; Smith M; Wells JL; Bartha R
    Neurobiol Aging; 2011 May; 32(5):802-10. PubMed ID: 19501936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
    Jones RS; Waldman AD
    Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Huang W; Alexander GE; Chang L; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Neurology; 2001 Aug; 57(4):626-32. PubMed ID: 11524470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
    Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
    Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.
    Calderón-Garcidueñas L; Mora-Tiscareño A; Melo-Sánchez G; Rodríguez-Díaz J; Torres-Jardón R; Styner M; Mukherjee PS; Lin W; Jewells V
    J Alzheimers Dis; 2015; 48(4):1065-75. PubMed ID: 26402110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.